Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis.
Greco G, Risi M, Masciocchi S, Businaro P, Rigoni E, Zardini E, Scaranzin S, Morandi C, Diamanti L, Foiadelli T, Giannoccaro MP, Morelli L, Liguori R, Barone P, Tozzo A, Passarini A, Gelibter S, Patti F, Banfi P, Simone AM, Bisecco A, Ruggieri M, Maimone D, Bruno G, Siliquini S, Bova S, Di Filippo M, Lanzillo R, Gallo A, Colombo E, Franciotta D, Gastaldi M; Neuroimmunology Platform (PNI) study group. Greco G, et al. Among authors: scaranzin s. J Neurol Neurosurg Psychiatry. 2024 Jun 6:jnnp-2024-333554. doi: 10.1136/jnnp-2024-333554. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 38844341
Progressive post infectious neurological syndromes with a poor outcome: Long term follow-up and neurofilament light chain quantification.
Businaro P, Currò R, Vegezzi E, Diamanti L, Bini P, Cosentino G, Alfonsi E, Farina LM, Colombo E, Tavazzi E, Cortese A, Scaranzin S, Gastaldi M, Marchioni E. Businaro P, et al. Among authors: scaranzin s. Mult Scler Relat Disord. 2023 Aug;76:104781. doi: 10.1016/j.msard.2023.104781. Epub 2023 May 28. Mult Scler Relat Disord. 2023. PMID: 37295322
Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response.
Bresciani L, Salvalaggio A, Vegezzi E, Visentin A, Fortuna A, Anglani M, Cacciavillani M, Masciocchi S, Scaranzin S, Carecchio M, Martinuzzi A, Gastaldi M, Briani C. Bresciani L, et al. Among authors: scaranzin s. J Peripher Nerv Syst. 2023 Sep;28(3):522-527. doi: 10.1111/jns.12565. Epub 2023 Jun 3. J Peripher Nerv Syst. 2023. PMID: 37246762
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study.
Gastaldi M, Foiadelli T, Greco G, Scaranzin S, Rigoni E, Masciocchi S, Ferrari S, Mancinelli C, Brambilla L, Mancardi M, Giacomini T, Ferraro D, Della Corte M, Gallo A, Di Filippo M, Benedetti L, Novi G, Versino M, Banfi P, Iorio R, Moiola L, Turco E, Sartori S, Nosadini M, Ruggieri M, Savasta S, Colombo E, Ballante E, Jarius S, Mariotto S, Franciotta D; NINA study group. Gastaldi M, et al. Among authors: scaranzin s. J Neurol Neurosurg Psychiatry. 2023 Mar;94(3):201-210. doi: 10.1136/jnnp-2022-330237. Epub 2022 Dec 2. J Neurol Neurosurg Psychiatry. 2023. PMID: 36460438
Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis.
Spagni G, Gastaldi M, Businaro P, Chemkhi Z, Carrozza C, Mascagna G, Falso S, Scaranzin S, Franciotta D, Evoli A, Damato V. Spagni G, et al. Among authors: scaranzin s. Neurol Neuroimmunol Neuroinflamm. 2022 Oct 21;10(1):e200038. doi: 10.1212/NXI.0000000000200038. Print 2023 Jan. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36270951 Free PMC article.
Improving laboratory diagnostics in myasthenia gravis.
Gastaldi M, Scaranzin S, Businaro P, Mobilia E, Benedetti L, Pesce G, Franciotta D. Gastaldi M, et al. Among authors: scaranzin s. Expert Rev Mol Diagn. 2021 Jun;21(6):579-590. doi: 10.1080/14737159.2021.1927715. Epub 2021 May 19. Expert Rev Mol Diagn. 2021. PMID: 33970749
15 results